The absence of longitudinal data limits the accuracy of high-throughput clinical phenotyping for identifying type 2 diabetes mellitus subjects.
Wei-Qi WeiCynthia L. LeibsonJeanine E. RansomAbel N. KhoChristopher G. ChutePublished in: Int. J. Medical Informatics (2013)
Keyphrases
- high throughput
- diabetes mellitus
- diabetic patients
- microarray
- genome wide
- biological data
- systems biology
- genomic data
- high accuracy
- dna sequencing
- proteomic data
- mass spectrometry
- protein protein interactions
- mass spectrometry data
- low latency
- data acquisition
- clinical practice
- blood glucose
- gene expression
- databases